54% rise in cervical cancer rate among young women in UK, as new research questions effectiveness of HPV vaccine

Disturbing article from the Independent:

Speaking about the 12 published HPV vaccine trials:

“Researchers at Newcastle University and Queen Mary University of London discovered the trials were not designed to identify cervical cancer, which takes decades to develop. 

Dr Claire Rees, lead researcher, said: “Trials may have overestimated efficacy by combining high-grade cervical disease with low-grade cervical changes that occur more frequently but often resolve spontaneously without progressing. We found insufficient data to clearly conclude that HPV vaccine prevents the higher-grade abnormal cell changes that can eventually develop into cervical cancer.

“Abnormal cell changes are likely to have been over diagnosed in the trials because cervical cytology was conducted at six to 12 months rather than at the normal screening interval of 36 months. This, too, means that the trials may have overestimated the efficacy of the vaccine, again because some of the lesions would have regressed spontaneously.”

Professor Allyson Pollock, co-author of the report, urged women to attend regular cervical screenings. She said: “We have good evidence that cervical screening significantly reduces the risk of cervical cancer in women regardless of whether they have been vaccinated.””

The HPV vaccine may create a false sense of security in young women as well, making them even less inclined to attend a screening, believing that they are protected because they received the vaccine.